Therapeutic Group: Cardiovascular Presentation Rocovas 5: Each tablet contains Rosuvastatin Calcium INN equivalent to Rosuvastatin 5 mg. Rocovas 10: Each tablet contains Rosuvastatin Calcium INN equivalent to Rosuvastatin 10 mg. Rocovas 20: Each tablet contains Rosuvastatin Calcium INN equivalent to Rosuvastatin 20 mg Description Rosuvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the […]
Therapeutic Group: Anesthetic / Critical Care Presentation Each vial contains Rocuronium Bromide INN 50 mg injection. Rocuron is supplied in a vial as a clear, aqueous solution for intravenous injection. Description Rocuronium Bromide is a fast onset, intermediate acting non-depolarizing neuromuscular blocking agent, possessing all of the characteristic pharmacological actions of this class of medicines […]
Therapeutic Group: Cardiovascular Presentation Roxarel 10: Each Tablet contains Rivaroxaban INN 10 mg. Roxarel 15: Each Tablet contains Rivaroxaban INN 15 mg. Description Rivaroxaban is a selective inhibitor of clotting factor Xa (FXa). It does not require a cofactor (such as Anti-thrombin III) for activity. Rivaroxaban inhibits free FXa and prothrombinase activity. Rivaroxaban indirectly inhibits […]
Therapeutic Group: Monoclonal Antibody Presentation Relyto 100: Each 10 ml solution for infusion contains Rituximab 100 mg. Relyto 500: Each 50 ml solution for infusion contains Rituximab 500 mg. Description Rituximab is a genetically engineered chimeric murine/human monoclonal IgG1 kappa antibody directed against the CD20 antigen. Rituximab has an approximate molecular weight of 145 kD. […]
Therapeutic Group: Drugs of Nervous System Presentation Frenia 1: Each tablet contains Risperidone BP 1 mg. Frenia 2: Each tablet contains Risperidone BP 2 mg. Frenia 4: Each tablet contains Risperidone BP 4 mg. Frenia Oral Solution: Each 1 ml solution contains Risperidone BP 1 mg. Description Risperidone is a selective monoaminergic antagonist having a […]
Therapeutic Group: Anti Bacterial Presentation Rifamax 200 tablet: Each tablet contains Rifaximin BP 200 mg. Rifamax 550 tablet: Each tablet contains Rifaximin BP 550 mg. Description Rifaximin is a semisynthetic, rifamycin-based non-systemic antibiotic. Very little of the drug will pass the gastrointestinal wall into the circulation as is common for other types of orally administered […]
Therapeutic Group: Anti Viral Presentation Celbarin: Each capsule contains Ribavirin BP 200 mg. Description Ribavirin is a nucleoside analogue with antiviral activity. Indications Ribavirin is indicated in combination with peg-interferon alpha-2a, 2b or interferon alpha injection for the treatment of chronic hepatitis C in patients with compensated liver disease previously untreated with alpha interferon or […]
Therapeutic Group: Skin Presentation Retapex ointment: Each gram ointment contains Retapamulin INN 10 mg. Description Retapamulin is a semi-synthetic pleuromutilin antibiotic. It is active against Staphylococcus aureus as well as Streptococcus pyogenes organisms. Retapamulin is bacteriostatic at minimum inhibitory concentration (MIC) against these pathogens. The bactericidal concentration against relevant pathogens is 1,000 times of the […]
Therapeutic Group: Anti Diabetic Presentation Nomopil 0.5 : Each tablet contains Repaglinide USP 0.5 mg. Nomopil 1 : Each tablet contains Repaglinide USP 1 mg. Nomopil 2 : Each tablet contains Repaglinide USP 2 mg. Description Repaglinide is an oral blood glucose-lowering drug of the meglitinide class used in the management of Type 2 diabetes […]
Therapeutic Group: µ-opioid agonisTherapeutic Group: µ-opioid agonis Presentation Remifen Injection: Each vial contains Remifentanil Hydrochloride BP equivalent to Remifentanil 1 mg as lyophilized powder. Description Remifentanil Hydrochloride is a µ-opioid agonist with rapid onset and peak effect and short duration of action. The µ-opioid activity of Remifentanil Hydrochloride is antagonized by opioid antagonists such as […]